• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

PACE Trial and PACE Trial Protocol

oceanblue

Guest
Messages
1,383
Location
UK
This, from their description of APT, bothers me a lot:
with advice not to undertake activities that demanded more than 70% of participants perceived energy envelopes

when I had pacing therapy (from one of the coauthors of the manual), there was no mention of a 70% limit: it seems a guaranteed way of making sure you don't increase what you can do overall. Or have I misunderstood something?
 

Angela Kennedy

Senior Member
Messages
1,026
Location
Essex, UK
Documentation around objections to the PACE trial raised since 2004:

http://www.theoneclickgroup.co.uk/documents/PACE/

My summary of flaws known about at the time:

http://www.theoneclickgroup.co.uk/documents/PACE/BREAKDOWN OF ISSUES.pdf

Original 'PACE report' written by Jane Bryant:

http://www.theoneclickgroup.co.uk/documents/PACE/THE PACE REPORT.pdf

My letter to Liam Donaldson (chief medical officer at the time) is linked there also, as is a press release and other information which may be useful to people. Although these are almost historical documents- they still hold up as problems in the PACE trial today (although additional key problems have been identified since), and provide an indication of how long objections to this trial have been going on, as well as possible discrepancies in PACE's final publication of their study in the Lancet.
 
Messages
44
Location
UK
How bloody depressing. Not only have we got to live with the day to day struggle of living a life like swimming through treacle, but now we have to fight all over again to explain to people who have watched the telly today that this is a chronic, debilitating, neuro-endo-immune condition and not just a bad day at the office!

I haven't been following this from the start, so forgive me if this is already accepted protocol, but it seems as though the PACE thing, the psycho lobby and the Lightning Process all release press releases to the media in a very sensationalist one-sided way. If we released a press release to the media announcing incredible breakthroughs with XMRV, presumably the governments have no way of stopping the press reporting on them? It seems as though the biomedical side is often writing letters in response to bad media rather than putting out very strong good media?

Unfortunately I think in these days of the media-led society, lobbying governments can only take us so far, but getting the truth out in the media (for example, inthe UK, if we could find someone at the Guardian willing to dig under the cover of these new announcements a bit) will force the governments to take notice because of public opinion.

Forgive me if this stuff is already happening.
 

oceanblue

Guest
Messages
1,383
Location
UK
Good article from NHS Choices, a website from the NHS that actually does quite a good job of reviewing research in a balanced way

Therapies 'moderately improve' CFS

The authors consider these to be “moderate improvements”, which is an appropriate conclusion. Compared with specialised medical care alone, CBT plus specialised medical care improved fatigue scores by 3.4 points on a 33-point scale, while GET plus specialised medical care improved scores by 3.2 points. Physical function score improvements were 7.1 for CBT and 9.4 for GET on a 100-point scale.

Which sums it up nicely, though you could argue that 3.4 point improvement on a 33-point scale etc is pretty poor. Those stark figures do show just how limited an impact the therapies have made. Given that
CBT was done on the basis of the fear avoidance theory of chronic fatigue syndrome
and
GET was done on the basis of deconditioning and exercise intolerance theories of chronic fatigue syndrome
and the results are so limited, you have to question the theories that CBT and GET are based on.

I think the PACE trial has provided powerful evidence that the biopsycosocial model is deeply flawed, from the greatest promoters of this model. Nice. We should be making the most of this evidence in due course.
 

Cort

Phoenix Rising Founder
Cort, have you fully read the article, they state:



They then go on to claim that 16% of APT, 30% of CBT, 28% of GET, 15% SMC patients returned to the normal range.

Of course claiming 60% on the SF-36 physical subscale as normal is a cruel joke.

edit- has anyone read the editorial?

I have alot to learn about the scales - just did a quick run through on the article. Starting to dig in now.
 

Cort

Phoenix Rising Founder
One way to get good comments on the various articles to rise to the top is to go through them such as on the NYT and recommend them.

Does anyone have the org responses? Have the CAA, IACFS/ME, UK groups responded?

Does anyone have the editorial - where to from here? I can't get seem to get it..if you have it can you post it?

Does any one have the Chalder or the other scales? It would be really useful to post them.
 

Cort

Phoenix Rising Founder
From the Medscape review:

Similarly, although 16% of the APT group and 15% of the SMC group were within normal ranges for both primary outcomes at the end of the study, 30% of the CBT group and 28% of the GET group reached this goal.

Not sure what normal for primary outcomes is but note that 70% of the CBT group did not reach 'normal'. What is a normal Chalder scale reading (ie healthy people would have), moderately ill and severely ill Chalder scale reading?

Although the findings show better efficacy of CBT and GET compared with APT, these treatments were still "only moderately effective," emphasizing that research into more effective treatments is needed.

Note that this was the aim of the study

"The aim of treatment was to change the behavioural and cognitive factors assumed to be responsible for perpetuation of the participant’s symptoms and disability."

YOu can come to a couple potential conclusions about this: (a)their assumption - that behavioral and cognitive factors are responsible for the symptoms and disability in this disorder is false - since their treatments had only moderate effects on CFS (and only on a subset of individuals) and/or b) they don't have particularly effective ways of addressing those factors.
 

Dolphin

Senior Member
Messages
17,567
File with all the questionnaires, etc used

Does any one have the Chalder or the other scales? It would be really useful to post them.
Hi Cort and all,

As the file is too large to upload into the library, I have uploaded a file to rapidshare.com which people can hopefully download for free http://rapidshare.com/files/448676468/11_PACE_Trial_Protocol.pdf . It does not involve torrents.

On page 162, one can see the Chalder fatigue scale.
It also includes the other questionnaires used.

Bye,
-------
If somebody could confirm they could download it, I'd appreciate it. Thanks.
 

Dolphin

Senior Member
Messages
17,567
I was able to download it. Do you know where to get the CBT and GET manuals? (phoenixcfs@gmail)
Thanks Cort

Manuals can now be downloaded from: http://www.pacetrial.org/trialinfo.html

I've copied below some direct links.

http://www.pacetrial.org/trialinfo.html

Trial information
Please note that the PACE trial closed to recruitment on 28 November 2008.

17 February 2011 update: PACE treatment manuals available

Treatment manuals (all PDFs): The treatment manuals are available free of charge for down-loading, so long as no changes are made to the manuals. Any use of these manuals should acknowledge the PACE trial (www.pacetrial.org).These manuals were used in the PACE trial by healthcare professionals and participants to support PACE trial treatments, which are described in the manuals. The results regarding efficacy and safety of these treatments are not yet published, but will be reported in the main paper of the PACE trial.

These treatments should only be delivered by appropriately qualified healthcare professionals, who have received appropriate training and continued supervision in their use. The treatments described were not designed to be stand-alone self-help approaches. No responsibility is accepted by the authors for the application of treatments described in these manuals outside of the PACE trial. The PACE trial team are unable to respond to queries or comments regarding the use of these manuals or the treatments described.

1.APT treatment manual
http://www.pacetrial.org/docs/apt-therapist-manual.pdf

2.APT participant manual
http://www.pacetrial.org/docs/apt-participant-manual.pdf

3.CBT treatment manual
http://www.pacetrial.org/docs/cbt-therapist-manual.pdf

4.CBT participant manual
http://www.pacetrial.org/docs/cbt-participant-manual.pdf NB copyright Constable and Robinson

5.GET treatment manual
http://www.pacetrial.org/docs/get-therapist-manual.pdf

6.GET participant manual
http://www.pacetrial.org/docs/get-participant-manual.pdf

7.SSMC treatment manual http://www.pacetrial.org/docs/ssmc-doctor-manual.pdf


March 2010 update: Data collection for the one year follow up has now been completed. The trial data is currently being analysed in preparation for publication of the findings. Further information regarding publication will be posted here when available.

To see the information on the trial given to potential participants, please click here http://www.pacetrial.org/TrialInfo.pdf (PDF, 42 KB)

Patient Clinic Leaflet http://www.pacetrial.org/PCL version 09.pdf
(PDF, 30 KB)



Participants' newsletters (all PDFs):

1.June 2006 http://www.pacetrial.org/docs/participantsnewsletter1.pdf (330
KB)
2.March 2007 http://www.pacetrial.org/docs/participantsnewsletter2.pdf
(345K)
3.December 2008 http://www.pacetrial.org/docs/participantsnewsletter3.pdf
(400 KB)



On-line trial protocol published on BioMed Central
http://www.biomedcentral.com/1471-2377/7/6
 

Dolphin

Senior Member
Messages
17,567
Given the harm that's been done to patients through the promotion the the psychosocial approach to CFS, they'd better come up with something damn near curative. Moderately alter questions for a fatigue questionnaire? I'd be pretty pissed.
Interesting way of looking at it.
 

Dolphin

Senior Member
Messages
17,567
I'm looking more and more at this and finding that the results were really very poor; there is very little indication of significant functional improvement.
You or others may not know or may have forgotten: when they initially applied for funding, they had actometers at the end or at the start. Improvements on that could have carried some weight. However, then they decided to drop them. I think it was they may have heard what happened with the Prins study which was known about in 2002 - see http://www.biomedcentral.com/1471-2377/7/6/comments#280543 Or maybe the Friedberg study did it.
 

Dolphin

Senior Member
Messages
17,567
Seems to be based on ref 31 but I think they need to spell out the reason for this major change.
It's free here in case anyone wants it:
http://www.mayoclinicproceedings.com/content/77/4/371.long

Mayo Clin Proc. 2002 Apr;77(4):371-83.

Methods to explain the clinical significance of health status measures.
Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR; Clinical Significance Consensus Meeting Group.

Department of Clinical Epidemiology and Biostatistics, McMaster University and Health Sciences Center, Hamilton, Ontario.

Abstract
One can classify ways to establish the interpretability of quality-of-life measures as anchor based or distribution based. Anchor-based measures require an independent standard or anchor that is itself interpretable and at least moderately correlated with the instrument being explored. One can further classify anchor-based approaches into population-focused and individual-focused measures. Population-focused approaches are analogous to construct validation and rely on multiple anchors that frame an individual's response in terms of the entire population (eg, a group of patients with a score of 40 has a mortality of 20%). Anchors for population-based approaches include status on a single item, diagnosis, symptoms, disease severity, and response to treatment. Individual-focused approaches are analogous to criterion validation. These methods, which rely on a single anchor and establish a minimum important difference in change in score, require 2 steps. The first step establishes the smallest change in score that patients consider, on average, to be important (the minimum important difference). The second step estimates the proportion of patients who have achieved that minimum important difference. Anchors for the individual-focused approach include global ratings of change within patients and global ratings of differences between patients. Distribution-based methods rely on expressing an effect in terms of the underlying distribution of results. Investigators may express effects in terms of between-person standard deviation units, within-person standard deviation units, and the standard error of measurement. No single approach to interpretability is perfect. Use of multiple strategies is likely to enhance the interpretability of any particular instrument.


That's a 2002 paper. They published their protocol in 2007.
 

Cort

Phoenix Rising Founder
I was going to ask about that. I saw that - something else to mention in the article..Thanks

You or others may not know or may have forgot: when they initially applied for funding, they had actometers at the end or at the start. Improvements on that could have carried some weight. However, then they decided to drop them. I think it was they may have heard what happened with the Prins study which was known about in 2002 - see http://www.biomedcentral.com/1471-2377/7/6/comments#280543 Or maybe the Friedberg study did it.
 

Cort

Phoenix Rising Founder
I was going to ask about that. I saw that - something else to mention in the article..Thanks

You or others may not know or may have forgot: when they initially applied for funding, they had actometers at the end or at the start. Improvements on that could have carried some weight. However, then they decided to drop them. I think it was they may have heard what happened with the Prins study which was known about in 2002 - see http://www.biomedcentral.com/1471-2377/7/6/comments#280543 Or maybe the Friedberg study did it.
 

Dolphin

Senior Member
Messages
17,567
I was going to ask about that. I saw that - something else to mention in the article..Thanks
Forgot to say: the participants still wore them before the trial. So there was no extra costs involved. Using 5m (US$8m) of taxpayers' money and they avoid using something which would give some hard data.
 

Dolphin

Senior Member
Messages
17,567
6 minute walking ability test - anyone have other data from healthy controls?

The only objective measure is the 6 minute walking ability test. Can anyone get some data from healthy controls from anywhere or normative data. One could do a t-test and compare against the results. The "best" result was 379m which doesn't seem that far - it's less than 1 lap of a 400m athletics track (it translates to an average speed of 3790m/hour - it's not saying they could do that amount of course in 1 hour).